Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Gene study helps breed disease-resistant salmon
atlantic salmon
The genetic marker is now being added to genetic tests used by farmers to select the best fish for breeding.
Discovery could cut losses and improve welfare

Scientists have discovered a genetic marker linked with resistance to a potentially devastating virus affecting farmed Atlantic salmon. It is hoped their findings will reduce losses and improve welfare.

Pancreas disease causes major economic losses to salmon farmers in the UK and Norway. Outbreaks also have a substantial impact on the welfare of farmed salmon, sometimes proving fatal. As such, it is one of the most problematic infectious diseases in the salmon farming industry.

Led by the University of Edinburgh's Roslin Institute, scientists examined commercial stocks of Atlantic salmon that had survived salmonid alphavirus infection.

They discovered a genetic marker, called a QTL, that is now being added to genetic tests used by farmers to select the best fish for breeding. It is hoped this will allow salmon farmers to breed fish that are more resilient to the virus.

"Based on these results, it is possible to take a small sample of fin tissue from a salmon, study its DNA and make accurate predictions on whether it is likely to produce offspring that have high resistance to salmonid alphavirus," explained Dr Ross Houston from the Roslin Institute.

"Breeding from fish that are more resistant has the potential to make a significant positive contribution to controlling disease outbreaks."

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.